NovoCure Chairman William Doyle's 2019 pay jumps 82% to $8.3M
NovoCure reports 2019 executive compensation
By ExecPay News
Published: April 27, 2020
NovoCure reported fiscal year 2019 executive compensation information on April 27, 2020.
In 2019, five NovoCure executives received on average a compensation package of $5.6M, a 57% increase compared to previous year.
Average pay of disclosed executives at NovoCure
William F. Doyle, Chairman, received $8.3M in total, which increased by 82% compared to 2018. 60% of Doyle's compensation, or $5M, was in option awards. Doyle also received $891K in non-equity incentive plan, $750K in salary, $1.7M in stock awards, as well as $18K in other compensation.
Asaf Danziger, Chief Executive Officer, received a compensation package of $7.3M, which increased by 60% compared to previous year. 61% of the compensation package, or $4.5M, was in option awards.
Michael Ambrogi, Chief Operating Officer, earned $4.7M in 2019, a 79% increase compared to previous year.
Wilhelmus Groenhuysen, Chief Financial Officer, received $4.2M in 2019, which increases by 21% compared to 2018.
Pritesh Shah, Chief Commercial Officer, earned $3.6M in 2019, a 18% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2020.